Intuitive Surgical (NASDAQ:ISRG) Given New $561.00 Price Target at BTIG Research

Intuitive Surgical (NASDAQ:ISRG) had its target price upped by BTIG Research from $535.00 to $561.00 in a research note issued to investors on Tuesday morning,Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Other equities analysts have also recently issued research reports about the company. Royal Bank of Canada lifted their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. Leerink Partners lifted their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird raised their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Finally, Raymond James lifted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $526.06.

Intuitive Surgical Trading Up 1.0 %

Intuitive Surgical stock opened at $542.10 on Tuesday. The firm has a market capitalization of $193.09 billion, a P/E ratio of 87.15, a PEG ratio of 5.39 and a beta of 1.39. The business has a 50-day moving average of $506.81 and a 200-day moving average of $466.29. Intuitive Surgical has a 1 year low of $304.50 and a 1 year high of $552.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Research analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,647 shares of company stock worth $26,170,907 over the last three months. Insiders own 0.80% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Hazlett Burt & Watson Inc. increased its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after purchasing an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. increased its stake in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after buying an additional 20 shares during the period. Ullmann Wealth Partners Group LLC raised its holdings in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after buying an additional 21 shares during the last quarter. Meeder Advisory Services Inc. boosted its position in Intuitive Surgical by 0.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after buying an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC grew its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after acquiring an additional 23 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.